Facts and controversies in mixed connective tissue disease
- PMID: 28864092
- DOI: 10.1016/j.medcli.2017.06.066
Facts and controversies in mixed connective tissue disease
Abstract
Mixed connective tissue disease (MCTD) is a systemic autoimmune rheumatic disease (SARD) characterised by the combination of clinical manifestations of systemic lupus erythematosus (SLE), cutaneous systemic sclerosis (SSc) and polymyositis-dermatomyositis, in the presence of elevated titers of anti-U1-RNP antibodies. Main symptoms of the disease are polyarthritis, hand oedema, Raynaud's phenomenon, sclerodactyly, myositis and oesophageal hypomobility. Although widely discussed, most authors today accept MCTD as an independent entity. Others, however, suggest that these patients may belong to subgroups or early stages of certain definite connective diseases, such as SLE or SSc, or are, in fact, SARD overlap syndromes.
Keywords: Anti-U1-RNP; Enfermedad mixta del tejido conectivo; Mixed connective tissue disease; Seronegative; Seronegativo.
Copyright © 2017 Elsevier España, S.L.U. All rights reserved.
Comment in
-
Facts in treatment of pulmonary arterial hypertension associated with mixed connective tissue disease.Med Clin (Barc). 2018 Dec 14;151(11):e63. doi: 10.1016/j.medcli.2018.02.026. Epub 2018 Apr 21. Med Clin (Barc). 2018. PMID: 29685309 English, Spanish. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources